292 related articles for article (PubMed ID: 36146679)
1. Epstein-Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients.
Brooks B; Tancredi C; Song Y; Mogus AT; Huang MW; Zhu H; Phan TL; Zhu H; Kadl A; Woodfolk J; Jerome KR; Zeichner SL
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146679
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of herpesviruses during COVID-19: A systematic review and meta-analysis.
Shafiee A; Teymouri Athar MM; Amini MJ; Hajishah H; Siahvoshi S; Jalali M; Jahanbakhshi B; Mozhgani SH
Rev Med Virol; 2023 May; 33(3):e2437. PubMed ID: 36880642
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients.
Bernal KDE; Whitehurst CB
Virus Res; 2023 Sep; 334():199157. PubMed ID: 37364815
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and Epstein-Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection.
Rousseau BA; Bhaduri-McIntosh S
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112929
[TBL] [Abstract][Full Text] [Related]
5. Higher frequency of Human herpesvirus-6 (HHV-6) viral DNA simultaneously with low frequency of Epstein-Barr virus (EBV) viral DNA in a cohort of multiple sclerosis patients from Rio de Janeiro, Brazil.
Pereira JG; Leon LAA; de Almeida NAA; Raposo-Vedovi JV; Fontes-Dantas FL; Farinhas JGD; Pereira VCSR; Alves-Leon SV; de Paula VS
Mult Scler Relat Disord; 2023 Aug; 76():104747. PubMed ID: 37267685
[TBL] [Abstract][Full Text] [Related]
6. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.
Flamand L; Stefanescu I; Ablashi DV; Menezes J
J Virol; 1993 Nov; 67(11):6768-77. PubMed ID: 8411380
[TBL] [Abstract][Full Text] [Related]
7. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.
Vojdani A; Vojdani E; Saidara E; Maes M
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851614
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Co-Infections for Human Gammaherpesvirus Infection and Associated Pathologies.
Chinna P; Bratl K; Lambarey H; Blumenthal MJ; Schäfer G
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685871
[TBL] [Abstract][Full Text] [Related]
9. Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression.
Tao C; Simpson-Yap S; Taylor B; Blizzard L; Lucas R; Ponsonby AL; Broadley S; van der Mei I;
Mult Scler Relat Disord; 2022 Mar; 59():103561. PubMed ID: 35131728
[TBL] [Abstract][Full Text] [Related]
10. Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysis.
Shafiee A; Amini MJ; Arabzadeh Bahri R; Jafarabady K; Salehi SA; Hajishah H; Mozhgani SH
Eur J Med Res; 2023 Aug; 28(1):278. PubMed ID: 37559096
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
[TBL] [Abstract][Full Text] [Related]
12. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19.
Simonnet A; Engelmann I; Moreau AS; Garcia B; Six S; El Kalioubie A; Robriquet L; Hober D; Jourdain M
Infect Dis Now; 2021 May; 51(3):296-299. PubMed ID: 33495765
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation.
Navarro-Bielsa A; Gracia-Cazaña T; Aldea-Manrique B; Abadías-Granado I; Ballano A; Bernad I; Gilaberte Y
An Bras Dermatol; 2023; 98(3):347-354. PubMed ID: 36803914
[TBL] [Abstract][Full Text] [Related]
14. [Study on the effect of human herpesvirus 6 on replication of Epstein-Barr virus].
Xia Q; Meng G; Ai Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Aug; 33(4):235-6. PubMed ID: 11717892
[TBL] [Abstract][Full Text] [Related]
15. The role of human herpesvirus-6, Epstein–Barr virus and cytomegalovirus infections in the etiopathogenesis of different types of cutaneous drug reactions.
Ozcan D; Seçkin D; Bilezikçi B; Arslan H
Int J Dermatol; 2010 Nov; 49(11):1250-4. PubMed ID: 21038542
[TBL] [Abstract][Full Text] [Related]
16. Frequent double infection with Epstein-Barr virus and human herpesvirus-6 in patients with acute infectious mononucleosis.
Bertram G; Dreiner N; Krueger GR; Ramon A; Ablashi DV; Salahuddin SZ; Balachandram N
In Vivo; 1991; 5(3):271-9. PubMed ID: 1654150
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection.
Descamps V; Mahe E; Houhou N; Abramowitz L; Rozenberg F; Ranger-Rogez S; Crickx B
Br J Dermatol; 2003 May; 148(5):1032-4. PubMed ID: 12786838
[TBL] [Abstract][Full Text] [Related]
18. [Reactivation of Epstein-Barr virus (
Solomay TV; Semenenko TA; Filatov NN; Vedunova SL; Lavrov VF; Smirnova DI; Gracheva AV; Faizuloev EB
Vopr Virusol; 2021 May; 66(2):152-161. PubMed ID: 33993685
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation.
Xie Y; Cao S; Dong H; Lv H; Teng X; Zhang J; Wang T; Zhang X; Qin Y; Chai Y; Yang L; Liu J; Wang R
BMC Infect Dis; 2021 Sep; 21(1):955. PubMed ID: 34525962
[TBL] [Abstract][Full Text] [Related]
20. Risk of a first clinical diagnosis of central nervous system demyelination in relation to human herpesviruses in the context of Epstein-Barr virus.
Lucas RM; Lay MJ; Grant J; Cherbuin N; Toi CS; Dear K; Taylor BV; Dwyer DE; ; Ponsonby AL
Eur J Neurol; 2023 Sep; 30(9):2752-2760. PubMed ID: 37306550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
